NO20014736L - Fremgangsmåte for en programmert kontrollert ovarie stimuleringsprotokoll - Google Patents

Fremgangsmåte for en programmert kontrollert ovarie stimuleringsprotokoll

Info

Publication number
NO20014736L
NO20014736L NO20014736A NO20014736A NO20014736L NO 20014736 L NO20014736 L NO 20014736L NO 20014736 A NO20014736 A NO 20014736A NO 20014736 A NO20014736 A NO 20014736A NO 20014736 L NO20014736 L NO 20014736L
Authority
NO
Norway
Prior art keywords
procedure
stimulation protocol
ovarian stimulation
controlled ovarian
programmed controlled
Prior art date
Application number
NO20014736A
Other languages
English (en)
Other versions
NO20014736D0 (no
NO327210B1 (no
Inventor
Juergen Engel
Hilde Rithmueller-Winzen
Original Assignee
Zentaris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Ag filed Critical Zentaris Ag
Publication of NO20014736D0 publication Critical patent/NO20014736D0/no
Publication of NO20014736L publication Critical patent/NO20014736L/no
Publication of NO327210B1 publication Critical patent/NO327210B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
NO20014736A 1999-03-31 2001-09-28 Farmasoytisk sett for behandling av infertilitet. NO327210B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12724199P 1999-03-31 1999-03-31
US13163299P 1999-04-28 1999-04-28
PCT/EP2000/002466 WO2000059542A1 (en) 1999-03-31 2000-03-21 Method for a programmed controlled ovarian stimulation protocol

Publications (3)

Publication Number Publication Date
NO20014736D0 NO20014736D0 (no) 2001-09-28
NO20014736L true NO20014736L (no) 2001-11-26
NO327210B1 NO327210B1 (no) 2009-05-11

Family

ID=26825471

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014736A NO327210B1 (no) 1999-03-31 2001-09-28 Farmasoytisk sett for behandling av infertilitet.

Country Status (28)

Country Link
US (1) US8173592B1 (no)
EP (1) EP1165138B1 (no)
JP (1) JP4616999B2 (no)
KR (1) KR100679880B1 (no)
CN (1) CN1346281B (no)
AR (1) AR023249A1 (no)
AT (1) ATE265862T1 (no)
AU (1) AU768544B2 (no)
BG (1) BG65270B1 (no)
BR (1) BR0009477A (no)
CA (1) CA2367214C (no)
CO (1) CO4970741A1 (no)
CZ (1) CZ299820B6 (no)
DE (1) DE60010452T2 (no)
DK (1) DK1165138T3 (no)
ES (1) ES2219331T3 (no)
HK (1) HK1044892B (no)
HU (1) HU229252B1 (no)
IL (2) IL145630A0 (no)
MX (1) MXPA01009862A (no)
NO (1) NO327210B1 (no)
NZ (1) NZ514964A (no)
PL (1) PL199569B1 (no)
PT (1) PT1165138E (no)
RU (1) RU2226395C2 (no)
SK (1) SK287244B6 (no)
TW (1) TWI241194B (no)
WO (1) WO2000059542A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0788799A3 (en) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
BRPI0407615B8 (pt) 2003-02-21 2021-05-25 Bayer Ip Gmbh sistema terapêutico transdérmico estável à radiação ultravioleta
US8668925B2 (en) 2003-12-12 2014-03-11 Bayer Intellectual Property Gmbh Transdermal delivery of hormones without the need of penetration enhancers
US8962013B2 (en) * 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
EP1719504A1 (de) * 2005-05-02 2006-11-08 Schering AG Festes transdermales therapeutisches System mit UV-Absorber
NZ566038A (en) * 2005-07-22 2011-06-30 Takeda Pharmaceutical The use of thieno(2,3-d)pyrimidine-2,4-dione derivatives which are gonadotropin releasing hormone (GnRH) antagonists as premature ovulation preventive agent
WO2014072350A1 (en) * 2012-11-09 2014-05-15 Iasomai Ab N-acetyl-l-cysteine for use in in vitro fertilization
EP3194581A4 (en) 2014-09-15 2018-04-25 Children's Medical Center Corporation Methods and compositions to increase somatic cell nuclear transfer (scnt) efficiency by removing histone h3-lysine trimethylation
DK3662925T3 (da) 2015-04-17 2021-06-28 Ferring Bv Sammensætning, der omfatter fsh, til behandling af infertilitet
WO2018060438A1 (en) * 2016-09-30 2018-04-05 Myovant Sciences Gmbh Methods of treating female infertility
RU2665967C1 (ru) * 2017-06-14 2018-09-05 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ стимуляции роста фолликулов в программах экстракорпорального оплодотворения у пациенток с бесплодием различного генеза и "бедным ответом на стимуляцию"
CN107982520A (zh) * 2017-12-25 2018-05-04 上海交通大学医学院附属第九人民医院 外源性MPA与hMG在制备动物模型药物中的应用
CN110570952B (zh) * 2018-06-05 2022-04-12 北京大学第三医院 预测拮抗剂方案下受试者卵巢低反应概率的系统及指导促性腺激素起始用药剂量选择的系统
CN110491505B (zh) * 2019-08-22 2021-06-01 北京大学第三医院（北京大学第三临床医学院） 预测受试者卵巢刺激过程中获得的卵母细胞数量的系统
CN113456801A (zh) * 2021-08-05 2021-10-01 浙江大学医学院附属第四医院 人绒毛膜促性腺激素在制备早发性卵巢功能不全患者的助孕药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016259A (en) * 1974-07-26 1977-04-05 Research Corporation Contraceptive polypeptides
EP0161063B1 (en) * 1984-04-03 1991-07-24 Serono Laboratories, Inc. Method of inducing ovulation
JP2959838B2 (ja) 1989-03-10 1999-10-06 アンドルシェルシュ・インコーポレイテッド エストロゲン感受性疾患の治療のための組合せ療法
US5470847A (en) * 1993-12-10 1995-11-28 Board Of Regents, The University Of Texas System Ovulation control by regulating nitric oxide levels with arginine derivatives
DK0769956T3 (da) 1994-07-22 2000-06-05 Hampton Roads Medical College Anvendelse af en GnRH-antogonist til fremstilling af et medikament til behandling af gonadal-steroidafhængige tilstande
EP0788799A3 (en) * 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
CA2200541C (en) 1997-01-22 2013-02-19 Philippe Bouchard Lhrh-antagonists in the treatment of fertility disorders
WO1998058647A1 (en) * 1997-06-23 1998-12-30 Mcneil-Ppc Acetaminophen and cisapride analgesics
HU228736B1 (en) * 1998-04-23 2013-05-28 Zentaris Ivf Gmbh Use of lhrh atnagonists in the production of pharmaceutical compostion for the treatment of fertility disorders

Also Published As

Publication number Publication date
KR20010105401A (ko) 2001-11-28
BG106045A (en) 2002-05-31
TWI241194B (en) 2005-10-11
HK1044892B (zh) 2011-06-30
IL145630A0 (en) 2002-06-30
PT1165138E (pt) 2004-09-30
BG65270B1 (bg) 2007-11-30
BR0009477A (pt) 2002-01-08
NO20014736D0 (no) 2001-09-28
JP2002541122A (ja) 2002-12-03
WO2000059542A1 (en) 2000-10-12
DE60010452T2 (de) 2005-04-14
CN1346281A (zh) 2002-04-24
HUP0200431A3 (en) 2004-04-28
NO327210B1 (no) 2009-05-11
AU4106900A (en) 2000-10-23
CO4970741A1 (es) 2000-11-07
EP1165138B1 (en) 2004-05-06
IL145630A (en) 2009-09-01
AR023249A1 (es) 2002-09-04
US8173592B1 (en) 2012-05-08
HU229252B1 (en) 2013-10-28
CZ20013495A3 (cs) 2002-06-12
KR100679880B1 (ko) 2007-02-07
AU768544B2 (en) 2003-12-18
NZ514964A (en) 2003-08-29
HK1044892A1 (en) 2002-11-08
JP4616999B2 (ja) 2011-01-19
CZ299820B6 (cs) 2008-12-03
SK13842001A3 (sk) 2002-09-10
ATE265862T1 (de) 2004-05-15
CA2367214A1 (en) 2000-10-12
RU2226395C2 (ru) 2004-04-10
CN1346281B (zh) 2010-04-14
HUP0200431A2 (hu) 2002-07-29
DE60010452D1 (de) 2004-06-09
MXPA01009862A (es) 2003-10-14
SK287244B6 (sk) 2010-04-07
PL351327A1 (en) 2003-04-07
PL199569B1 (pl) 2008-10-31
DK1165138T3 (da) 2004-08-30
EP1165138A1 (en) 2002-01-02
CA2367214C (en) 2008-07-29
ES2219331T3 (es) 2004-12-01
WO2000059542A9 (en) 2001-11-22

Similar Documents

Publication Publication Date Title
CY2016002I2 (el) Ν-υποκατεστημενο καρβαμουλοξυαλκυλιο - παραγωγα αζολιου
NO20002585L (no) Fremgangsmåte for komplettering av en brönn
FI20000863A0 (fi) Uusi hoitomenetelmä
FI20000564A0 (fi) Menetelmä nanolaminaattien valmistamiseksi
DE60043707D1 (de) D regler
DE60033364D1 (de) Steuereinrichtung
NO20014736L (no) Fremgangsmåte for en programmert kontrollert ovarie stimuleringsprotokoll
DE60036654D1 (de) Gerät zum Aufsetzen einer Prothese
DE69933849D1 (de) Manipulatorsteuerung
DE60003592D1 (de) Drehwinkel-Verstelleinheit
ID30091A (id) Metode untuk menyiapkan l-fenilefrina hidroklorida
DK1223887T3 (da) Implantatindstilling
DE60018492D1 (de) Drehwinkel-Verstelleinheit
DE60034981D1 (de) Manipulatorsteuerung
DE59911113D1 (de) Herzschrittmacher
DE60029189D1 (de) Kupplungssteuerungsgerät
DE60014697D1 (de) Patientisolierende programmschnittstelle zum programmieren von hörgeräten
DE50012502D1 (de) Vorrichtung zum Steuern einer Einrichtung
DE60024023D1 (de) Nockenwellenversteller
DE69916133D1 (de) Elektro-neuro-adaptiver stimulator
DE50012266D1 (de) Betätigungseinrichtung
FI990386A (fi) Ohjainlaite
ATE315025T1 (de) Ethansulfonyl-piperidin-derivate
DE50003324D1 (de) Pulverkraftbetriebenes Setzgerät
DE50012720D1 (de) Pulverkraftbetriebenes Setzgerät

Legal Events

Date Code Title Description
MK1K Patent expired